Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel B Jones

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Nephron. Clinical Practice|November 18, 2014
Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitisRachel B Jones
Annals of the Rheumatic Diseases|March 22, 2019
Response to: 'MYCYC, unravelling the long road ahead in ANCA-associated vasculitis' by Jain <i>et al</i>Lorraine Harper, Rachel B Jones
Clinical Journal of the American Society of Nephrology : CJASN|July 7, 2019
Treatment of Relapses in ANCA-Associated VasculitisMark McClure, Rachel B Jones
Nature Reviews. Nephrology|December 18, 2021
Improving outcomes in glomerular diseaseAndreas Kronbichler, Rachel B Jones
Rheumatology (Oxford, England)|June 17, 2021
Therapeutic dilemmas in relapsing renal ANCA-associated vasculitisOndrej Suchanek, David R W Jayne, Rachel B Jones
Rheumatology (Oxford, England)|June 17, 2021
Pregnancy following rituximab for orbital eosinophilic angiocentric fibrosisSonja C Mansfield Smith, Gerry Clare, Rachel B Jones
Current Opinion in Rheumatology|April 29, 2009
What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?Rachel B Jones, Michael Walsh, Kenneth G C Smith
Rheumatology (Oxford, England)|March 12, 2025
Highlights from the breakout session: optimising new treatmentsLucy Francis, Amrita Dhutia, Charles Pusey, et al.
Kidney International|February 13, 2021
Glomerular basement membrane nephritis: crescentic renal inflammation and immunosuppressive intervention in the time of the severe acute respiratory syndrome coronavirus 2 pandemicSilke R Brix, Rachel B Jones, David R W Jayne
Nephron. Clinical Practice|May 21, 2010
Treatment of primary systemic vasculitis with the inosine monophosphate dehydrogenase inhibitor mycophenolic acidThomas F Hiemstra, Rachel B Jones, David R W Jayne
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Nephron. Clinical Practice|November 18, 2014
Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitisRachel B Jones
Annals of the Rheumatic Diseases|March 22, 2019
Response to: 'MYCYC, unravelling the long road ahead in ANCA-associated vasculitis' by Jain <i>et al</i>Lorraine Harper, Rachel B Jones
Clinical Journal of the American Society of Nephrology : CJASN|July 7, 2019
Treatment of Relapses in ANCA-Associated VasculitisMark McClure, Rachel B Jones
Nature Reviews. Nephrology|December 18, 2021
Improving outcomes in glomerular diseaseAndreas Kronbichler, Rachel B Jones
Rheumatology (Oxford, England)|June 17, 2021
Therapeutic dilemmas in relapsing renal ANCA-associated vasculitisOndrej Suchanek, David R W Jayne, Rachel B Jones
Rheumatology (Oxford, England)|June 17, 2021
Pregnancy following rituximab for orbital eosinophilic angiocentric fibrosisSonja C Mansfield Smith, Gerry Clare, Rachel B Jones
Current Opinion in Rheumatology|April 29, 2009
What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?Rachel B Jones, Michael Walsh, Kenneth G C Smith
Rheumatology (Oxford, England)|March 12, 2025
Highlights from the breakout session: optimising new treatmentsLucy Francis, Amrita Dhutia, Charles Pusey, et al.
Kidney International|February 13, 2021
Glomerular basement membrane nephritis: crescentic renal inflammation and immunosuppressive intervention in the time of the severe acute respiratory syndrome coronavirus 2 pandemicSilke R Brix, Rachel B Jones, David R W Jayne
Nephron. Clinical Practice|May 21, 2010
Treatment of primary systemic vasculitis with the inosine monophosphate dehydrogenase inhibitor mycophenolic acidThomas F Hiemstra, Rachel B Jones, David R W Jayne
Pageof 6